Abstract:Bacillus thuringiensis (Bt) is a Gram-positive soil bacterium that is widely and safely applied in the environment as an insecticide for combatting insect pests that damage crops or are disease vectors. Dominant active ingredients made by Bt are insect-killing crystal (Cry) proteins released as crystalline inclusions upon bacterial sporulation. Some Bt Cry proteins, e.g., Cry5B (formally Cry5Ba1), target nematodes (roundworms) and show exceptional promise as anthelmintics (cures for parasitic nematode diseases). We have recently described inactivated bacteria with cytosolic crystal(s) (IBaCC) in which bioactive Bt Cry crystals (containing Cry5B) are fully contained within the cytosol of dead bacterial ghosts. Here, we demonstrate that these IBaCC-trapped Cry5B crystals can be liberated and purified away from cellular constituents, yielding purified cytosolic crystals (PCC). Cry5B PCC contains similar to 95% Cry5B protein out of the total protein content. Cry5B PCC is highly bioactive against parasitic nematode larvae and adults in vitro. Cry5B PCC is also highly active in vivo against experimental human hookworm and Ascaris infections in rodents. The process was scaled up to the 100-liter scale to produce PCC for a pilot study to treat two foals infected with the ascarid Parascaris spp. Single-dose Cry5B PCC brought the fecal egg counts of both foals to zero. These studies describe the process for the scalable production of purified Bt crystals and define a new and attractive pharmaceutical ingredient form of Bt Cry proteins. IMPORTANCE Bacillus thuringiensis crystal proteins are widely and safely used as insecticides. Recent studies have shown they also can cure gastrointestinal parasitic worm (nematode) infections when ingested. However, reproducible, scalable, and practical techniques for purifying these proteins have been lacking. Here, we address this severe limitation and present scalable and practical methods for large-scale purification of potently bioactive B. thuringiensis crystals and crystal proteins. The resultant product, called purified cytosolic crystals (PCC), is highly compatible with ingestible drug delivery and formulation. Furthermore, there are growing applications in agriculture and insect control where access to large quantities of purified crystal proteins is desirable and where these methods will find great utility.

Characterization of insecticidal crystal protein cry gene of Bacillus thuringiensis from soil of Sichuan Basin and cloning of novel holotype cry gene]

Characterization of Insecticidal Crystal Protein Cry Gene of Bacillus Thuringiensis from Soil of Sichuan Basin, China and Cloning of Novel Haplotypes Cry Gene

Cloning and Characterization of Two Novel Crystal Protein Genes, cry54Aa1 and cry30Fa1 , from Bacillus thuringiensis Strain BtMC28

Identification of cry1I-type genes from Bacillus thuringiensis strains and characterization of a novel cry1I-type gene.

Cloning and Characterization of Two Novel Crystal Protein Genes, and , from Strain BtMC28

Efficient and Scalable Process to Produce Novel and Highly Bioactive Purified Cytosolic Crystals from Bacillus Thuringiensis

Purified cytosolic crystals from Bacillus thuringiensis as a novel active pharmaceutical ingredient (API)

Multiple cry Genes in Bacillus thuringiensis Strain BTG Suggest a Broad-Spectrum Insecticidal Activity

The Pesticidal Cry6Aa Toxin from Bacillus Thuringiensis is Structurally Similar to HlyE-family Alpha Pore-Forming Toxins.

High-throughput screening for novel Bacillus thuringiensis insecticidal proteins revealed evidence that the bacterium exchanges Domain III to enhance its insecticidal activity

Characterization of Two Novel Bacillus thuringiensis Cry8 Toxins Reveal Differential Specificity of Protoxins or Activated Toxins against Chrysomeloidea Coleopteran Superfamily

Identification of cry genes in Bacillus thuringiensis by multiplex real-time PCR

Characterization of Chimeric Bacillus Thuringiensis Vip3 Toxins

Construction of Modified Bacillus Thuringiensis Cry1ac Genes for Transgenic Crop Through Multi Site-directed Mutagenesis

Characterization of the individual domains of the Bacillus thuringiensis Cry2Aa implicates Domain I as a possible binding site to Helicoverpa armigera

Structural and biophysical characterization of Bacillus thuringiensis insecticidal proteins Cry34Ab1 and Cry35Ab1.

Comparative analysis of genomics and proteomics in Bacillus thuringiensis 4.0718

Whole genome sequencing of a novel Bacillus thuringiensis isolated from Assam soil

Identification and analysis of toxins in novel Bacillus thuringiensis strain Bt S3076-1 against Spodoptera frugiperda and Helicoverpa armigera (Lep.: Noctuidae)

A high-throughput, in-vitro assay for Bacillus thuringiensis insecticidal proteins

Cry3Aa11: a new Cry3Aa delta-endotoxin from a local isolate of Bacillus thuringiensis